TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting

SAN DIEGO and IRVINE, Calif., Sept. 28, 2023 /PRNewswire/ — TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, is thrilled to announce it is bringing BNCT to this […]


Exploring the Future of Innovation in San Diego

UC San Diego-powered startups, incubators and accelerator programs took center stage during the second annual Innovation Day at Petco Park, highlighting the university’s world-class, dynamic innovation ecosystem. Click here to view original post


RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting

HAYWARD, Calif.–(BUSINESS WIRE)– #ASTRO23–RefleXion® Medical, a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 1-4, 2023 […]

No Picture
San Diego Biotech Jobs

Senior Scientist, Immunohistochemistry/Image Analysis, Translational Pathology – Bristol Myers Squibb – San Diego, CA

Under the leadership of an MD pathologist, the group provides pathobiology scientific expertise, diagnostic consultation, & histopathology technical support.From Bristol-Myers… Click here to view original post


Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

BURLINGAME, Calif.–(BUSINESS WIRE)–Tallac Therapeutics, Inc., a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced the acceptance of two abstracts (related to TAC-001 and TAC-003) at the […]


Cardiff’s stock jumps after sharing promising PhII data for its PLK1 inhibitor onvansertib in pancreatic cancer

Cardiff Oncology saw its stock rise after it announced positive Phase II data from its PLK1 inhibitor onvansertib in second-line metastatic pancreatic ductal adenocarcinoma (mPDAC), spurring plans for an investigator-led trial in first-line treatment. The […]


Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the acceptance of three abstracts for a […]


Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem’s Phexxi Patents Expire

— Padagis Determined They Will Not Challenge the Phexxi Patents — — Evofem Has Phexxi Patent Protection Through 2033 — SAN DIEGO, Sept. 27, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that […]


Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

MONROE TOWNSHIP, N.J. & OXFORD, England–(BUSINESS WIRE)–Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced presentations on POSLUMA® (flotufolastat F 18) injection (formerly known […]


Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer’s disease and Huntington’s disease

Roche gains exclusive worldwide rights to develop, manufacture and commercialize the investigational medicines discovered by Ionis Ionis to receive a $60 million upfront payment CARLSBAD, Calif., Sept. 27, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: […]